San Antonio, TX, March 13, 2023 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (#" JETS Outperforming the Market U.S. Global Investors
Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma 25-04-2025, 18:43